Literature DB >> 15181140

Isolating effects of microscopic nonuniform distributions of (131)I on labeled and unlabeled cells.

Prasad V S V Neti1, Roger W Howell.   

Abstract

UNLABELLED: Radiopharmaceuticals are generally distributed nonuniformly in tissue. At the microscopic level, only a fraction of the cells in tissue are labeled. Consequently, the labeled cells receive an absorbed dose from radioactivity within the cell (self-dose) as well as an absorbed dose from radioactivity in surrounding cells (cross-dose). On the other hand, unlabeled cells only receive a cross-dose. This work uses a novel approach to examine the lethal effects of microscopic nonuniformities of (131)I individually on the labeled and unlabeled cells.
METHODS: A multicellular tissue model was used to investigate the lethality of microscopic nonuniform distributions of (131)I. Mammalian cells (V79) were dyed with CFDA-SE (carboxy fluorescein diacetate succinimidyl ester) and labeled with (131)I-iododeoxyuridine ((131)IdU). The dyed labeled cells were then mixed with equal numbers of unlabeled cells, and 3-dimensional tissue constructs (4 x 10(6) cells) were formed by centrifugation in a small tube. This resulted in a uniform distribution of (131)I at the macroscopic level but nonuniform distribution at the multicellular level, wherein 50% of the cells were labeled. The multicellular clusters were maintained at 10.5 degrees C for 72 h to allow (131)I decays to accumulate. The clusters were then dismantled and the labeled (dyed) and unlabeled (undyed) cells were separately seeded for colony formation using a fluorescence-activated cell sorter.
RESULTS: The unlabeled cells, which received only a cross-dose, exhibited a mean lethal dose D(37) of 4.0 +/- 0.3 Gy. In contrast, the labeled cells received both a self-dose and a cross-dose. Isolating the effects of the self-dose resulted in a D(37) of 1.2 +/- 0.3 Gy, which was about 3.3 times more toxic per unit dose than the cross-dose. The reason for these differences appears to be primarily related to the higher relative biological effectiveness of the self-dose delivered by (131)IdU compared with the cross-dose. Theoretical modeling of the killing of labeled and unlabeled cells was achieved by considering the cellular self-doses and cross-doses.
CONCLUSION: Cellular self-doses and cross-doses play an important role in determining the biological response of tissue to microscopic nonuniform distributions of (131)I. Prediction of the biological response requires that both self-doses and cross-doses be considered along with their relative lethality per unit dose.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15181140      PMCID: PMC2911233     

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  21 in total

1.  Efficient mutation induction by 125I and 131I decays in DNA of human cells.

Authors:  J M Whaley; J B Little
Journal:  Radiat Res       Date:  1990-07       Impact factor: 2.841

2.  Induction of sperm head abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation, dose rate, and presence of radioprotectors.

Authors:  D V Rao; V R Narra; R W Howell; V K Lanka; K S Sastry
Journal:  Radiat Res       Date:  1991-01       Impact factor: 2.841

3.  The MIRD perspective 1999. Medical Internal Radiation Dose Committee.

Authors:  R W Howell; B W Wessels; R Loevinger; E E Watson; W E Bolch; A B Brill; N D Charkes; D R Fisher; M T Hays; J S Robertson; J A Siegel; S R Thomas
Journal:  J Nucl Med       Date:  1999-01       Impact factor: 10.057

4.  Comparison of cellular and conventional dosimetry in assessing self-dose and cross-dose delivered to the cell nucleus by electron emissions of 99mTC, 123I, 111In, 67Ga and 201T1.

Authors:  M Faraggi; I Gardin; J L Stievenart; B D Bok; D Le Guludec
Journal:  Eur J Nucl Med       Date:  1998-03

5.  Biological consequence of nuclear versus cytoplasmic decays of 125I: cysteamine as a radioprotector against Auger cascades in vivo.

Authors:  D V Rao; V R Narra; R W Howell; K S Sastry
Journal:  Radiat Res       Date:  1990-11       Impact factor: 2.841

6.  Rdiotoxicity of intracellular 67Ga, 125I and 3H. Nuclear versus cytoplasmic radiation effects in murine L1210 leukaemia.

Authors:  K G Hofer; C R Harris; J M Smith
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1975-09

7.  Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine.

Authors:  G M Makrigiorgos; A I Kassis; J Baranowska-Kortylewicz; K D McElvany; M J Welch; K S Sastry; S J Adelstein
Journal:  Radiat Res       Date:  1989-06       Impact factor: 2.841

8.  Macroscopic dosimetry for radioimmunotherapy: nonuniform activity distributions in solid tumors.

Authors:  R W Howell; D V Rao; K S Sastry
Journal:  Med Phys       Date:  1989 Jan-Feb       Impact factor: 4.071

9.  Radioprotection against lethal damage caused by chronic irradiation with radionuclides in vitro.

Authors:  R W Howell; S M Goddu; A Bishayee; D V Rao
Journal:  Radiat Res       Date:  1998-10       Impact factor: 2.841

10.  The question of relative biological effectiveness and quality factor for auger emitters incorporated into proliferating mammalian cells.

Authors:  R W Howell; D V Rao; D Y Hou; V R Narra; K S Sastry
Journal:  Radiat Res       Date:  1991-12       Impact factor: 2.841

View more
  12 in total

Review 1.  Challenges and progress in predicting biological responses to incorporated radioactivity.

Authors:  R W Howell; P V S V Neti; M Pinto; B I Gerashchenko; V R Narra; E I Azzam
Journal:  Radiat Prot Dosimetry       Date:  2007-02-06       Impact factor: 0.972

2.  Biological response to nonuniform distributions of (210)Po in multicellular clusters.

Authors:  Prasad V S V Neti; Roger W Howell
Journal:  Radiat Res       Date:  2007-09       Impact factor: 2.841

3.  Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE".

Authors:  Elif Hindié; Christophe Champion; Paolo Zanotti-Fregonara; Domenico Rubello; Nicole Colas-Linhart; Laura Ravasi; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-09       Impact factor: 9.236

4.  Survival of tumor and normal cells upon targeting with electron-emitting radionuclides.

Authors:  Didier Rajon; Wesley E Bolch; Roger W Howell
Journal:  Med Phys       Date:  2013-01       Impact factor: 4.071

5.  Flow cytometry-assisted Monte Carlo simulation predicts clonogenic survival of cell populations with lognormal distributions of radiopharmaceuticals and anticancer drugs.

Authors:  John M Akudugu; Roger W Howell
Journal:  Int J Radiat Biol       Date:  2011-12-09       Impact factor: 2.694

6.  Modeling multicellular response to nonuniform distributions of radioactivity: differences in cellular response to self-dose and cross-dose.

Authors:  Roger W Howell; Prasad V S V Neti
Journal:  Radiat Res       Date:  2005-02       Impact factor: 2.841

7.  Monte Carlo simulation of irradiation and killing in three-dimensional cell populations with lognormal cellular uptake of radioactivity.

Authors:  Roger W Howell; Didier Rajon; Wesley E Bolch
Journal:  Int J Radiat Biol       Date:  2011-11-30       Impact factor: 2.694

8.  Patient exposures and consequent risks from nuclear medicine procedures.

Authors:  Roger W Howell
Journal:  Health Phys       Date:  2011-03       Impact factor: 1.316

9.  Cellular Response to Exponentially Increasing and Decreasing Dose Rates: Implications for Treatment Planning in Targeted Radionuclide Therapy.

Authors:  Jay H Solanki; Thomas Tritt; Jordan B Pasternack; Julia J Kim; Calvin N Leung; Jason D Domogauer; Nicholas W Colangelo; Venkat R Narra; Roger W Howell
Journal:  Radiat Res       Date:  2017-05-25       Impact factor: 2.841

10.  Radiation-induced reductions in transporter mRNA levels parallel reductions in intestinal sugar transport.

Authors:  Marjolaine Roche; Prasad V S V Neti; Francis W Kemp; Amit Agrawal; Alicia Attanasio; Véronique Douard; Anjali Muduli; Edouard I Azzam; Edward Norkus; Michael Brimacombe; Roger W Howell; Ronaldo P Ferraris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-11       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.